Press release dated January 02, 2026, titled "Press Release on financial results for Q2FY26 "
As filed · CORONA Remedies Limited has informed the Exchange regarding a press release dated January 02, 2026, titled "Press Release on financial results for Q2FY26 ".
EarningsMajormateriality 75 out of 100
What happened
FactCORONA Remedies Limited has informed the Exchange regarding a press release dated January 02, 2026, titled "Press Release on financial results for Q2FY26 ". Regulations, 2015, please find enclosed herewith the Press Release on Financial Results of. For CORONA Remedies Limited.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We continue to target 15% revenue growth and 20% PAT growth over the FY27. (management committed by FY27)
- Our FY27 guidance remains unchanged. We continue to target 15% organic revenue growth and about 1.5% to 2% ino (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%